NCT01582321View on ClinicalTrials.gov

Investigation of the Influence of Gender on Cardiovascular Function

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Cardiovascular Function
Interventions
BIOLOGICAL

Typhoid vaccine

The typhoid vaccine is composed of purified polysaccharide from S. typhi capsule 25 micrograms contained in 0.5 ml solution

DRUG

Cantharidin

0.1% cantharidin solution in acetone from 0.7% stock solution of cantharone is prepared and applied immediately. 10 μl of cantharidin per disc.

Trial Locations (1)

EC1M 6BQ

William Harvey Heart Centre, Barts & The London Medical School, London

All Listed Sponsors
lead

Queen Mary University of London

OTHER

NCT01582321 - Investigation of the Influence of Gender on Cardiovascular Function | Biotech Hunter | Biotech Hunter